QGEN Competitors & Alternatives
Compare Qiagen NV with similar stocks in the same industry
Diagnostics & Research
QGEN
Main Stock$37.20
Tradestie Score
59
Market Cap
$10.04B
P/E Ratio
18.9
Revenue Growth
0.0%
Analyst Upside
+17.8%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$99.90
|
$10.65B | 48.1 | 55 | Compare |
|
TECH
Bio-Techne Corp.
|
$56.26
|
$9.33B | 82.8 | 56 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$186.60
|
$8.39B | - | 59 | Compare |
|
BIO
Bio-Rad Laboratories, Inc.Class A
|
$270.32
|
$8.06B | 46.9 | 53 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$130.83
|
$7.81B | - | 59 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$56.20
|
$6.00B | - | 60 | Compare |
|
BLLN
BLLN
|
$104.28
|
$4.84B | 191.2 | 60 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$15.84
|
$4.60B | 38.6 | 56 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$58.08
|
$3.26B | - | 64 | Compare |
More QGEN Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry